Paris Daily Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Paris Daily Reporter.

Press releases published on April 15, 2026

Apr. 15, 2026

Launch Details and Principal Management Team for Hannover House MyFlix Streaming Service to be announced at Cannes

Indeterminate EIN Presswire

Apr. 15, 2026

DUST Identity Launches Theseus, an End-to-End Aerospace Material & Parts Authentication Platform

Indeterminate EIN Presswire

Apr. 15, 2026

Luxury Tribe 2026 Showcases France & Italy as Deepening Priority Destinations for India's Luxury Traveller

Indeterminate EIN Presswire

Apr. 15, 2026

Cliniques de Greffe de Cheveux en Turquie – Guide Spécialement Destiné à la France

Indeterminate EIN Presswire

Apr. 15, 2026

Horizon Europe’s SWIFTT project concludes with Copernicus-based forest management tool to prevent threats to EU forests

Indeterminate EIN Presswire

Apr. 15, 2026

Sarla Technologies Joins the AVEVA Partner Ecosystem as a System Integrator with Focus on AVEVA PI System

Indeterminate EIN Presswire

Apr. 15, 2026

Ad Scientiam launches U.S. subsidiary and expands deployment of MSCopilot® following FDA registration

Indeterminate EIN Presswire

Apr. 15, 2026

Curapath and Nacalai Tesque Partner to Expand Access to next generation Polymers and PEG-Free Shielding Lipids in Japan

Indeterminate EIN Presswire

Apr. 15, 2026

Climate finance rising on paper — but not in reality, new analysis warns

Indeterminate EIN Presswire

Apr. 15, 2026

Constellium to Report First Quarter 2026 Results on April 29, 2026

Indeterminate GlobeNewswire

Apr. 15, 2026

Clipperton publishes new research report: Office Of The CFO - A Universe in Expansion and Consolidation

Indeterminate GlobeNewswire

Apr. 15, 2026

Clipperton Finance publie un nouveau rapport de recherche : Office of the CFO – Un univers en expansion et en consolidation

Indeterminate GlobeNewswire

Apr. 15, 2026

OSE Immunotherapeutics to Present a Novel, First-in-Class, FPR2 Agonist Monoclonal Antibody in the Resolution of Chronic Inflammation at the AAI 2026 Meeting

Indeterminate GlobeNewswire

Apr. 15, 2026

OSE Immunotherapeutics présentera un nouvel anticorps monoclonal, first-in-class, agoniste de FPR2 dans la résolution de l’inflammation chronique au Congrès 2026 de l’AAI

Indeterminate GlobeNewswire